PharmaEngine, Inc. (TPEX: 4162)
Taiwan
· Delayed Price · Currency is TWD 93.60
+0.40 (0.43%)
Jan 20, 2025, 1:30 PM CST
PharmaEngine Revenue
PharmaEngine had revenue of 218.22M TWD in the quarter ending September 30, 2024, a decrease of -11.27%. This brings the company's revenue in the last twelve months to 831.92M, up 12.60% year-over-year. In the year 2023, PharmaEngine had annual revenue of 767.67M with 17.31% growth.
Revenue (ttm)
831.92M
Revenue Growth
+12.60%
P/S Ratio
16.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | 1.06B | 741.97M | 236.27% |
| Dec 31, 2019 | 314.04M | 20.61M | 7.02% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 49.98M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Center Laboratories | 1.57B |